skip to main content

Troponin Interpretation in CKD — EECC MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCoronary Artery DiseaseTroponin Interpretation in CKDEECC

A 72-year-old man with NSTEMI has a troponin rise to 500 ng/L (99th percentile 14 ng/L). He also has CKD stage 4 (eGFR 18 mL/min). His baseline troponin was previously measured at 55 ng/L. How should troponin be interpreted in CKD?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Chronic kidney disease causes chronically elevated baseline troponin levels due to reduced renal clearance and subclinical myocardial injury — a significant rise-and-fall pattern (delta >20% from a known elevated baseline) is more diagnostic of acute MI than a single elevated value

CKD causes chronically elevated hs-cTn levels through: (1) reduced renal clearance of troponin fragments; (2) subclinical chronic myocardial injury (from LVH, volume overload, uraemic cardiomyopathy); (3) increased myocardial wall stress. In CKD patients: (1) a single elevated troponin is NOT diagnostic of acute MI — many CKD stage 4-5 patients have baseline troponin above the 99th percentile; (2) the DYNAMIC rise-and-fall pattern is key: a >20% change from a known baseline (or serial values showing significant delta) suggests acute myocardial injury; (3) the 0h/1h algorithm can still be applied but with CKD-adjusted interpretation. The 2023 ESC ACS Guidelines recommend serial troponin measurements (not single values) in CKD. This patient's rise from baseline 55 to 500 ng/L (>20% change) with a clinical presentation consistent with ACS supports the MI diagnosis.

Reference: ESC (2023): ACS Guidelines; Fourth Universal Definition of MI